Hims & Hers Health, Inc. (HIMS) Institutional Ownership

Ownership Summary

A total of 447 institutions have reported a stake in Hims & Hers Health, Inc. (NYSE:HIMS) as of December 2025, according to recent 13F filings with the SEC.

• These investors collectively held 76.8% of the company's total shares outstanding in December 2025, down from 84.5% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by -3.46%, with a year-over-year an increase of 14.03% in the count of filers.
• Of these 447 institutional investors, 253 increased their holdings in Hims & Hers Health, while 150 of them reduced positions, and 44 investors maintained their exposure.
• The aggregate institutional position in Hims & Hers Health now stands at 193.90Mn shares as of December 2025, after investors decreased their holdings (down by 6.96Mn shares quarter on quarter which is up 24.96Mn shares year over year).
• With 26.57Mn shares, BlackRock, Inc. commands the largest institutional position in Hims & Hers Health as of December 31, 2025, equating to 10.53% of the company.
• Among the most significant buyers of Hims & Hers Health during December 2025 were NORGES BANK (1.91Mn), UBS Group AG (1.83Mn), CITADEL ADVISORS LLC (1.80Mn), GOLDMAN SACHS GROUP INC (1.68Mn), Squarepoint Ops LLC (1.63Mn).
• Leading sellers of Hims & Hers Health stock in December 2025 included FARALLON CAPITAL MANAGEMENT LLC (7.36Mn), Capital World Investors (4.46Mn), Tidal Investments LLC (4.39Mn), RENAISSANCE TECHNOLOGIES LLC (4.28Mn), MORGAN STANLEY (3.35Mn).
• The top 10 institutional holders of Hims & Hers Health for the quarter ending December 2025 included BlackRock, Inc. (26.57Mn), VANGUARD GROUP INC (20.93Mn), JPMORGAN CHASE & CO (18.84Mn), Capital World Investors (14.32Mn), GOLDMAN SACHS GROUP INC (11.16Mn), JANE STREET GROUP, LLC (8.00Mn), STATE STREET CORP (7.31Mn), GEODE CAPITAL MANAGEMENT, LLC (5.51Mn), RENAISSANCE TECHNOLOGIES LLC (4.82Mn), UBS Group AG (4.70Mn).